BiondVax Pharmaceuticals Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
63.50
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.10
|
0.00
|
0.10
|
100.00%
|
|
2022-09-30
|
-0.10
|
0.01
|
0.11
|
110.00%
|
|
2022-06-30
|
-1.05
|
-0.20
|
0.85
|
80.95%
|
|
2022-03-31
|
-1.00
|
-2.00
|
-1.00
|
-100.00%
|
|
2021-12-31
|
-0.85
|
-2.70
|
-1.85
|
-217.65%
|
|
2021-09-30
|
0.00
|
-0.01
|
0.00
|
0.00%
|
|
2021-06-30
|
0.00
|
-0.01
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.01
|
-1.14
|
-1.13
|
-11300.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-09-30
|
-2.19
|
|
2021-12-31
|
-3.86
|
|
2020-12-31
|
-4.49
|
|
2018-12-31
|
-0.13
|
|
2017-12-31
|
-1.29
|